Preoperative Anti–tumor Necrosis Factor Therapy in Patients with Ulcerative Colitis Is Not Associated with an Increased Risk of Infectious and Noninfectious Complications After Ileal Pouch–anal Anastomosis

The Impact of Preoperative Serum Anti-TNFα Therapy Levels on Early Postoperative Outcomes in Inflammatory Bowel Disease Surgery

(2015) Cheryl Lau et al.   ANNALS OF SURGERY

Anti–Tumor Necrosis Factor-α Antibody Therapy Management Before and After Intestinal Surgery for Inflammatory Bowel Disease

(2015) Stefan D. Holubar et al.   INFLAMMATORY BOWEL DISEASES

Effect of Preoperative Biologic Drugs on Complications and Function After Restorative Proctocolectomy with Primary Ileal Pouch Formation

(2015) Francesco Selvaggi et al.   INFLAMMATORY BOWEL DISEASES

Long-term Prognosis of Ulcerative Colitis and its Temporal Change Between 1977 and 2013: A Hospital-based Cohort Study from Korea

(2014) Ho-Su Lee et al.   Journal of Crohns & Colitis

Should biologic agents be stopped before surgery for inflammatory bowel disease?

(2014) Karen Zaghiyan et al.   Expert Review of Gastroenterology & Hepatology

Ileal Pouch Anal Anastomosis

(2013) Victor Warren Fazio et al.   ANNALS OF SURGERY

Operative Strategy Modifies Risk of Pouch-related Outcomes in Patients With Ulcerative Colitis on Preoperative Anti-Tumor Necrosis Factor-α Therapy

(2013) Jinyu Gu et al.   DISEASES OF THE COLON & RECTUM

Risk of Surgery for Inflammatory Bowel Diseases Has Decreased Over Time: A Systematic Review and Meta-analysis of Population-Based Studies

(2013) Alexandra D. Frolkis et al.   GASTROENTEROLOGY

Changes in medical treatment and surgery rates in inflammatory bowel disease: a nationwide cohort study 1979–2011

(2013) Christine Rungoe et al.   GUT

Possible Overuse of 3-Stage Procedures for Active Ulcerative Colitis

(2013) Caitlin W. Hicks et al.   JAMA Surgery

Decreasing Colectomy Rates for Ulcerative Colitis: A Population-Based Time Trend Study

(2012) Gilaad G Kaplan et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

The Epidemiology of Colectomy in Ulcerative Colitis: Results From a Population-Based Cohort

(2012) Laura E Targownik et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Preoperative biological therapy and short-term outcomes of abdominal surgery in patients with inflammatory bowel disease

(2012) Matti Waterman et al.   GUT

Development and validation of a homogeneous mobility shift assay for the measurement of infliximab and antibodies-to-infliximab levels in patient serum

(2012) Shui-Long Wang et al.   JOURNAL OF IMMUNOLOGICAL METHODS

Anti-TNF-alpha therapies do not increase early postoperative complications in patients with inflammatory bowel disease. An Italian single-center experience

(2011) Gianluca Rizzo et al.   INTERNATIONAL JOURNAL OF COLORECTAL DISEASE

Colectomy Rate Comparison After Treatment of Ulcerative Colitis With Placebo or Infliximab

(2009) William J. Sandborn et al.   GASTROENTEROLOGY

Trough serum infliximab: a predictive factor of clinical outcome for infliximab treatment in acute ulcerative colitis

(2009) C H Seow et al.   GUT

Risk factors and characteristics of extent progression in ulcerative colitis

(2009) María Josefina Etchevers et al.   INFLAMMATORY BOWEL DISEASES

Corticosteroids but not infliximab increase short-term postoperative infectious complications in patients with ulcerative colitis

(2009) M. Ferrante et al.   INFLAMMATORY BOWEL DISEASES

Preoperative infliximab treatment in patients with ulcerative and indeterminate colitis does not increase rate of conversion to emergent and multistep abdominal surgery

(2009) Liliana Bordeianou et al.   INTERNATIONAL JOURNAL OF COLORECTAL DISEASE

Preoperative Steroid Use and Risk of Postoperative Complications in Patients With Inflammatory Bowel Disease Undergoing Abdominal Surgery

(2008) Venkataraman Subramanian et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Natural History of Severe Ulcerative Colitis in a Community-Based Health Plan

(2008) James Allison et al.   Clinical Gastroenterology and Hepatology

Infliximab in Ulcerative Colitis is Associated with an Increased Risk of Postoperative Complications After Restorative Proctocolectomy

(2008) I. J. Mor et al.   DISEASES OF THE COLON & RECTUM

Perioperative Treatment with Infliximab in Patients with Crohn’s Disease and Ulcerative Colitis is Not Associated with an Increased Rate of Postoperative Complications

(2008) Hiroko Kunitake et al.   JOURNAL OF GASTROINTESTINAL SURGERY